LEXX
Price
$0.72
Change
-$0.06 (-7.69%)
Updated
Jan 15, 04:57 PM (EDT)
Capitalization
19.46M
6 days until earnings call
Intraday BUY SELL Signals
NKTX
Price
$1.97
Change
-$0.10 (-4.83%)
Updated
Jan 15, 04:59 PM (EDT)
Capitalization
147.03M
63 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

LEXX vs NKTX

Header iconLEXX vs NKTX Comparison
Open Charts LEXX vs NKTXBanner chart's image
Lexaria Bioscience
Price$0.72
Change-$0.06 (-7.69%)
Volume$190
Capitalization19.46M
Nkarta
Price$1.97
Change-$0.10 (-4.83%)
Volume$29.44K
Capitalization147.03M
LEXX vs NKTX Comparison Chart in %
LEXX
Daily Signal:
Gain/Loss:
NKTX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
LEXX vs. NKTX commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LEXX is a Hold and NKTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (LEXX: $0.78 vs. NKTX: $2.07)
Brand notoriety: LEXX and NKTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LEXX: 29% vs. NKTX: 80%
Market capitalization -- LEXX: $19.46M vs. NKTX: $147.03M
LEXX [@Biotechnology] is valued at $19.46M. NKTX’s [@Biotechnology] market capitalization is $147.03M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LEXX’s FA Score shows that 0 FA rating(s) are green whileNKTX’s FA Score has 1 green FA rating(s).

  • LEXX’s FA Score: 0 green, 5 red.
  • NKTX’s FA Score: 1 green, 4 red.
According to our system of comparison, NKTX is a better buy in the long-term than LEXX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

LEXX’s TA Score shows that 5 TA indicator(s) are bullish while NKTX’s TA Score has 4 bullish TA indicator(s).

  • LEXX’s TA Score: 5 bullish, 4 bearish.
  • NKTX’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, LEXX is a better buy in the short-term than NKTX.

Price Growth

LEXX (@Biotechnology) experienced а +12.03% price change this week, while NKTX (@Biotechnology) price change was +0.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -0.44%. For the same industry, the average monthly price growth was +2.31%, and the average quarterly price growth was +42.34%.

Reported Earning Dates

LEXX is expected to report earnings on Jan 21, 2026.

NKTX is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (-0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NKTX($147M) has a higher market cap than LEXX($19.5M). LEXX YTD gains are higher at: 26.742 vs. NKTX (11.892). LEXX has higher annual earnings (EBITDA): -11.31M vs. NKTX (-112.74M). NKTX has more cash in the bank: 282M vs. LEXX (4.63M). LEXX has less debt than NKTX: LEXX (117K) vs NKTX (76.6M). LEXX has higher revenues than NKTX: LEXX (616K) vs NKTX (0).
LEXXNKTXLEXX / NKTX
Capitalization19.5M147M13%
EBITDA-11.31M-112.74M10%
Gain YTD26.74211.892225%
P/E RatioN/AN/A-
Revenue616K0-
Total Cash4.63M282M2%
Total Debt117K76.6M0%
FUNDAMENTALS RATINGS
LEXX: Fundamental Ratings
LEXX
OUTLOOK RATING
1..100
52
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
88
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
LEXXNKTX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 8 days ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 29 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
LEXX
Daily Signal:
Gain/Loss:
NKTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTVA69.941.09
+1.58%
Corteva
NMAX7.580.09
+1.20%
Newsmax Inc
MIRM90.650.21
+0.23%
Mirum Pharmaceuticals
GAUZ0.97-0.07
-6.73%
Gauzy Ltd
AIRJ3.43-0.54
-13.60%
AirJoule Technologies Corporation

LEXX and

Correlation & Price change

A.I.dvisor tells us that LEXX and MIST have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LEXX and MIST's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LEXX
1D Price
Change %
LEXX100%
-3.34%
MIST - LEXX
28%
Poorly correlated
+5.18%
BTAI - LEXX
27%
Poorly correlated
-2.93%
EPRX - LEXX
27%
Poorly correlated
+1.44%
MDXG - LEXX
26%
Poorly correlated
-3.23%
NKTX - LEXX
26%
Poorly correlated
+0.98%
More

NKTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, NKTX has been loosely correlated with SYRE. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NKTX jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NKTX
1D Price
Change %
NKTX100%
+0.98%
SYRE - NKTX
50%
Loosely correlated
+5.17%
IBRX - NKTX
49%
Loosely correlated
+7.09%
BEAM - NKTX
49%
Loosely correlated
+2.49%
FATE - NKTX
46%
Loosely correlated
+5.88%
CRBU - NKTX
46%
Loosely correlated
+1.26%
More